Robert Rose
Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Papillomaviridae | 25 | 1989 | 37 |
Why?
| Virion | 11 | 1991 | 24 |
Why?
| Viral Vaccines | 6 | 1999 | 35 |
Why?
| Antibodies, Viral | 18 | 1989 | 104 |
Why?
| Oncogene Proteins, Viral | 9 | 1993 | 29 |
Why?
| Capsid Proteins | 9 | 1993 | 19 |
Why?
| Dengue Virus | 8 | 2006 | 6 |
Why?
| Capsid | 5 | 1990 | 14 |
Why?
| Papillomavirus Vaccines | 4 | 2001 | 19 |
Why?
| Papillomavirus Infections | 7 | 1994 | 39 |
Why?
| Immunoglobulin G | 8 | 1999 | 191 |
Why?
| Antigen-Presenting Cells | 1 | 2007 | 40 |
Why?
| Research Personnel | 1 | 2006 | 17 |
Why?
| Virus Replication | 5 | 1993 | 90 |
Why?
| Gene Transfer Techniques | 1 | 2007 | 59 |
Why?
| Receptors, IgG | 4 | 2006 | 30 |
Why?
| Plasmids | 1 | 2007 | 122 |
Why?
| Mice, Inbred BALB C | 7 | 1999 | 176 |
Why?
| Neutralization Tests | 8 | 1992 | 37 |
Why?
| Enterotoxins | 2 | 2001 | 15 |
Why?
| Enzyme-Linked Immunosorbent Assay | 9 | 1991 | 224 |
Why?
| Vaccines, Synthetic | 2 | 2001 | 30 |
Why?
| Bacterial Toxins | 2 | 2001 | 24 |
Why?
| Animals | 26 | 1989 | 1031 |
Why?
| Mice | 16 | 1992 | 623 |
Why?
| Adjuvants, Immunologic | 2 | 2001 | 73 |
Why?
| CpG Islands | 1 | 2001 | 26 |
Why?
| Skin Transplantation | 3 | 1993 | 39 |
Why?
| Escherichia coli Proteins | 2 | 2001 | 40 |
Why?
| Antibodies, Neutralizing | 2 | 2009 | 11 |
Why?
| Dengue Vaccines | 2 | 2009 | 3 |
Why?
| Dengue | 3 | 2007 | 5 |
Why?
| Severe Combined Immunodeficiency | 2 | 1994 | 9 |
Why?
| Escherichia coli | 2 | 1989 | 143 |
Why?
| Antigens, Viral | 4 | 1989 | 53 |
Why?
| Recombinant Proteins | 6 | 1989 | 290 |
Why?
| Tumor Virus Infections | 5 | 1992 | 31 |
Why?
| DNA, Viral | 6 | 1989 | 98 |
Why?
| Administration, Oral | 3 | 1999 | 170 |
Why?
| Uterine Cervical Neoplasms | 3 | 2003 | 55 |
Why?
| Viral Proteins | 2 | 1993 | 71 |
Why?
| Epitopes | 3 | 1989 | 86 |
Why?
| Humans | 31 | 1989 | 1856 |
Why?
| Baculoviridae | 2 | 1990 | 23 |
Why?
| Female | 16 | 1992 | 1643 |
Why?
| Immunoglobulin A | 3 | 1999 | 39 |
Why?
| Rabbits | 5 | 1989 | 252 |
Why?
| Condylomata Acuminata | 4 | 1991 | 16 |
Why?
| Cervical Intraepithelial Neoplasia | 3 | 2003 | 16 |
Why?
| B-Lymphocytes | 4 | 2006 | 134 |
Why?
| Active Transport, Cell Nucleus | 2 | 2002 | 55 |
Why?
| HIV Infections | 2 | 2006 | 136 |
Why?
| Membrane Glycoproteins | 1 | 1994 | 154 |
Why?
| Antibodies, Blocking | 1 | 2010 | 7 |
Why?
| Cyclooxygenase 2 | 2 | 2006 | 77 |
Why?
| Open Reading Frames | 1 | 1990 | 56 |
Why?
| Genotype | 4 | 1998 | 175 |
Why?
| Vaccinia | 1 | 2009 | 7 |
Why?
| Immunity, Humoral | 1 | 2009 | 12 |
Why?
| Bandages | 1 | 1989 | 22 |
Why?
| Cyclooxygenase 2 Inhibitors | 1 | 2009 | 45 |
Why?
| Vaccinia virus | 1 | 2009 | 22 |
Why?
| Viral Fusion Proteins | 1 | 2009 | 9 |
Why?
| Catheterization, Central Venous | 1 | 1989 | 46 |
Why?
| Sepsis | 1 | 1989 | 73 |
Why?
| Cross Infection | 1 | 1989 | 46 |
Why?
| Lymphocyte Activation | 3 | 2001 | 137 |
Why?
| Molecular Sequence Data | 5 | 1993 | 404 |
Why?
| Vero Cells | 4 | 2006 | 20 |
Why?
| Respiratory Syncytial Virus, Human | 1 | 2009 | 15 |
Why?
| Antibody Specificity | 2 | 1994 | 71 |
Why?
| T-Lymphocytes | 4 | 2001 | 182 |
Why?
| Cercopithecus aethiops | 4 | 2006 | 67 |
Why?
| Human papillomavirus 16 | 1 | 2006 | 5 |
Why?
| Antigen-Antibody Complex | 1 | 2006 | 34 |
Why?
| Base Sequence | 4 | 1993 | 371 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2006 | 47 |
Why?
| beta Karyopherins | 2 | 2002 | 9 |
Why?
| Spleen | 1 | 2007 | 129 |
Why?
| Antibody Formation | 1 | 2006 | 89 |
Why?
| Green Fluorescent Proteins | 1 | 2007 | 105 |
Why?
| Monocytes | 1 | 2008 | 124 |
Why?
| Melanoma, Experimental | 1 | 2005 | 13 |
Why?
| Vagina | 2 | 2001 | 30 |
Why?
| Mice, Nude | 3 | 1992 | 72 |
Why?
| Skin | 3 | 1993 | 177 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 2005 | 20 |
Why?
| Macrophages | 1 | 2007 | 148 |
Why?
| Repressor Proteins | 1 | 2007 | 96 |
Why?
| Antigens, CD | 1 | 2006 | 128 |
Why?
| Gene Therapy | 1 | 2007 | 89 |
Why?
| Mice, Inbred C57BL | 2 | 2005 | 318 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 2005 | 52 |
Why?
| Antigens, Neoplasm | 1 | 2005 | 56 |
Why?
| Viral Plaque Assay | 3 | 2006 | 18 |
Why?
| Mutagenesis, Site-Directed | 2 | 2001 | 126 |
Why?
| HIV-1 | 2 | 2006 | 93 |
Why?
| Solanum tuberosum | 1 | 2003 | 1 |
Why?
| Plants, Genetically Modified | 1 | 2003 | 2 |
Why?
| Cervix Mucus | 1 | 2003 | 4 |
Why?
| Mice, SCID | 2 | 1993 | 61 |
Why?
| Recombinant Fusion Proteins | 3 | 1989 | 189 |
Why?
| Cells, Cultured | 5 | 1990 | 447 |
Why?
| Moths | 2 | 1990 | 16 |
Why?
| Transplantation, Heterologous | 3 | 1993 | 57 |
Why?
| Cell Movement | 1 | 2005 | 163 |
Why?
| Mutagenesis | 1 | 2003 | 74 |
Why?
| Cell Line | 3 | 1994 | 375 |
Why?
| Cervix Uteri | 1 | 2002 | 38 |
Why?
| Cloning, Molecular | 3 | 1989 | 183 |
Why?
| Cross Reactions | 3 | 1989 | 63 |
Why?
| Vaccines, DNA | 1 | 2001 | 16 |
Why?
| Flow Cytometry | 3 | 2006 | 216 |
Why?
| Vaginal Smears | 2 | 2006 | 31 |
Why?
| Cytokines | 1 | 2002 | 207 |
Why?
| RNA, Viral | 2 | 1992 | 91 |
Why?
| Adult | 8 | 1989 | 1317 |
Why?
| Prevalence | 2 | 2006 | 281 |
Why?
| Protein Structure, Tertiary | 2 | 2006 | 163 |
Why?
| Leukocyte L1 Antigen Complex | 1 | 1994 | 6 |
Why?
| Penile Neoplasms | 1 | 1994 | 12 |
Why?
| Blotting, Western | 2 | 1989 | 275 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1993 | 43 |
Why?
| Temperature | 1 | 1994 | 137 |
Why?
| Lepidoptera | 1 | 1993 | 4 |
Why?
| RNA, Messenger | 2 | 1989 | 394 |
Why?
| Macromolecular Substances | 1 | 1993 | 92 |
Why?
| Microscopy, Electron | 1 | 1993 | 178 |
Why?
| Immunoblotting | 1 | 1993 | 119 |
Why?
| Oligodeoxyribonucleotides | 1 | 1993 | 86 |
Why?
| Interferon-alpha | 1 | 1993 | 43 |
Why?
| DNA Replication | 1 | 1993 | 75 |
Why?
| Respiratory Tract Diseases | 1 | 1992 | 34 |
Why?
| HeLa Cells | 2 | 2002 | 107 |
Why?
| Vaccines, Subunit | 1 | 2010 | 10 |
Why?
| Kenya | 1 | 2010 | 4 |
Why?
| Genetic Vectors | 1 | 1993 | 139 |
Why?
| Washington | 1 | 2010 | 12 |
Why?
| Uterine Cervical Dysplasia | 1 | 2010 | 8 |
Why?
| Viral Envelope Proteins | 1 | 2010 | 26 |
Why?
| Pan troglodytes | 1 | 2009 | 13 |
Why?
| Male | 6 | 1992 | 1553 |
Why?
| Vaccines, Virosome | 1 | 2009 | 3 |
Why?
| Interferon-gamma | 2 | 2001 | 133 |
Why?
| Aedes | 1 | 2009 | 4 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 2009 | 38 |
Why?
| Automation | 1 | 2009 | 27 |
Why?
| Codon | 1 | 1989 | 41 |
Why?
| Antigens, Bacterial | 1 | 1989 | 44 |
Why?
| DNA-Binding Proteins | 1 | 1993 | 204 |
Why?
| Polymerase Chain Reaction | 2 | 1992 | 279 |
Why?
| Antibody-Dependent Enhancement | 1 | 2007 | 5 |
Why?
| Leukocytes, Mononuclear | 1 | 2008 | 67 |
Why?
| Models, Molecular | 1 | 2009 | 102 |
Why?
| Immunoglobulin Class Switching | 1 | 2006 | 17 |
Why?
| Pyrazoles | 1 | 2006 | 42 |
Why?
| Phagocytosis | 1 | 2006 | 51 |
Why?
| Mice, Knockout | 1 | 2009 | 265 |
Why?
| COS Cells | 1 | 2006 | 73 |
Why?
| Vaccines, Edible | 1 | 2005 | 1 |
Why?
| Mice, Inbred A | 1 | 2005 | 15 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 2005 | 23 |
Why?
| Schizosaccharomyces | 1 | 2005 | 11 |
Why?
| Mutation, Missense | 1 | 2006 | 59 |
Why?
| Lymphocyte Count | 1 | 2005 | 38 |
Why?
| Ovalbumin | 1 | 2005 | 32 |
Why?
| Amino Acid Sequence | 1 | 2009 | 319 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2005 | 85 |
Why?
| Antigen Presentation | 1 | 2005 | 28 |
Why?
| Prospective Studies | 1 | 1989 | 545 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 243 |
Why?
| Antibodies, Monoclonal | 1 | 2009 | 241 |
Why?
| Middle Aged | 3 | 1993 | 1161 |
Why?
| Lymph Nodes | 1 | 2005 | 106 |
Why?
| Antibodies, Neoplasm | 1 | 2003 | 28 |
Why?
| Gene Expression Regulation | 1 | 1989 | 277 |
Why?
| Cell Line, Tumor | 1 | 2005 | 208 |
Why?
| Mice, Transgenic | 1 | 2005 | 209 |
Why?
| Adolescent | 2 | 2001 | 891 |
Why?
| Aged | 2 | 2003 | 988 |
Why?
| New York | 1 | 2006 | 422 |
Why?
| Longitudinal Studies | 1 | 2003 | 195 |
Why?
| Cell Proliferation | 1 | 2005 | 227 |
Why?
| Interleukin-5 | 1 | 2001 | 20 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 49 |
Why?
| Interleukin-4 | 1 | 2002 | 62 |
Why?
| Carcinoma, Squamous Cell | 1 | 2003 | 111 |
Why?
| Species Specificity | 1 | 2001 | 186 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2002 | 91 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2002 | 113 |
Why?
| Cell Nucleus | 1 | 2003 | 169 |
Why?
| Time Factors | 1 | 2003 | 896 |
Why?
| Subrenal Capsule Assay | 1 | 1994 | 3 |
Why?
| DNA Probes, HPV | 1 | 1994 | 3 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1993 | 88 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 48 |
Why?
| Enhancer Elements, Genetic | 1 | 1993 | 43 |
Why?
| Chromosome Mapping | 1 | 1993 | 107 |
Why?
| Electrophoresis, Agar Gel | 1 | 1992 | 27 |
Why?
| Immune Sera | 1 | 1992 | 56 |
Why?
| Random Allocation | 1 | 1992 | 160 |
Why?
| Warts | 1 | 1991 | 13 |
Why?
| Biopsy | 1 | 1991 | 207 |
Why?
| Skin Diseases | 1 | 1991 | 69 |
Why?
| Kidney | 1 | 1993 | 223 |
Why?
| Reference Values | 1 | 1991 | 278 |
Why?
| Bovine papillomavirus 1 | 1 | 1989 | 6 |
Why?
| beta-Galactosidase | 1 | 1989 | 63 |
Why?
| Infant, Newborn | 1 | 1993 | 389 |
Why?
| Immunohistochemistry | 1 | 1992 | 355 |
Why?
| Follow-Up Studies | 1 | 1993 | 553 |
Why?
| Child, Preschool | 1 | 1992 | 554 |
Why?
| Child | 1 | 1992 | 749 |
Why?
|
|
Rose's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
